ANGPTL8-binding agents and methods of use thereof
- 专利权人:
- Inc.;NGM Biopharmaceuticals
- 发明人:
- CHU, Chun,DING, Xunshan,LIU, Zhonghao,WANG, Yan,YIN, Yiyuan,ZHAI, Wenwu
- 申请号:
- AU2018366122
- 公开号:
- AU2018366122A1
- 申请日:
- 2018.11.08
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要:
- The present disclosure provides binding agents, such as antibodies, that specifically bind angiopoietin-iike protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Pharmaceutical combination comprising a dual angiopoietin-2 / Dll4 binding agent and an anti-VEGF-R agent
- Pharmaceutical combination comprising a dual angiopoietin-2 / Dll4 binding agent and an anti-VEGF agent
- ANGIOPOIETIN-2拮抗劑與VEGF-A、KDR和/或FLTL拮抗劑結合用於治療癌症
- Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer
- COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCER